EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Survivin Small Molecules Inhibitors: Recent Advances and Challenges

Najah Albadari, Wei Li iD

Molecules · 01.02.2023 · 28 (3) · 1376

DOI: 10.3390/molecules28031376 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 01.02.2023. Verfasst von Najah Albadari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Survivin, as a member of the inhibitor of apoptosis proteins (IAPs) family, acts as a suppressor of apoptosis and plays a central role in cell division. Survivin has been considered as an important cancer drug target because it is highly expressed in many types of human cancers, while it is effectively absent from terminally differentiated normal tissues. Moreover, survivin is involved in tumor cell resistance to chemotherapy and radiation. Preclinically, downregulation of survivin expression or function reduced tumor growth induced apoptosis and sensitized tumor cells to radiation and chemotherapy in different human tumor models. This review highlights the role of survivin in promoting cellular proliferation and inhibiting apoptosis and summarizes the recent advances in and challenges of developing small-molecule survivin inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansSurvivinInhibitor of Apoptosis ProteinsApoptosisCell Line, Tumor

Stichwörter der Autor:innen

apoptosischemoresistancemitosissurvivinsurvivin small molecules inhibitors

Substanzen

SurvivinInhibitor of Apoptosis ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Wei Li

Förderung

  • National Cancer Institute

Zitieren

APA

Albadari, N., & Li, W. (2023). Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules, 28(3), 1376. https://doi.org/10.3390/molecules28031376

Vancouver

Albadari N, Li W. Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules. 2023;28(3):1376. doi:10.3390/molecules28031376

BibTeX
@article{Albadari2023,
  author = {Albadari, Najah and Li, Wei},
  title = {Survivin Small Molecules Inhibitors: Recent Advances and Challenges},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {3},
  pages = {1376},
  doi = {10.3390/molecules28031376}
}
Kostenlos starten →